Viveve Medical Inc
OTC:VIVE

Watchlist Manager
Viveve Medical Inc Logo
Viveve Medical Inc
OTC:VIVE
Watchlist
Price: 0.0002 USD Market Closed
Market Cap: $2.1k

Viveve Medical Inc
Selling, General & Administrative

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Viveve Medical Inc
Selling, General & Administrative Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Viveve Medical Inc
OTC:VIVE
Selling, General & Administrative
-$13.5m
CAGR 3-Years
22%
CAGR 5-Years
11%
CAGR 10-Years
-18%
Boston Scientific Corp
NYSE:BSX
Selling, General & Administrative
-$7.1B
CAGR 3-Years
-15%
CAGR 5-Years
-13%
CAGR 10-Years
-9%
Edwards Lifesciences Corp
NYSE:EW
Selling, General & Administrative
-$2.1B
CAGR 3-Years
-9%
CAGR 5-Years
-11%
CAGR 10-Years
-10%
Stryker Corp
NYSE:SYK
Selling, General & Administrative
-$8.2B
CAGR 3-Years
-11%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Abbott Laboratories
NYSE:ABT
Selling, General & Administrative
-$12.4B
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
-6%
Intuitive Surgical Inc
NASDAQ:ISRG
Selling, General & Administrative
-$2.4B
CAGR 3-Years
-11%
CAGR 5-Years
-14%
CAGR 10-Years
-14%
No Stocks Found

Viveve Medical Inc
Glance View

Market Cap
2.1k USD
Industry
Health Care

Viveve Medical, Inc. engages in the design, development, manufacture, and marketing of platform medical technology. The company is headquartered in Englewood, Colorado and currently employs 47 full-time employees. The firm's CMRF technology is delivered through a radiofrequency (RF) generator, handpiece and treatment tip, that collectively, is referred to as the Viveve System. The Viveve System is marketed for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence (SUI), which is known as Viveve treatment. The Viveve System uses a method of delivering monopolar radiofrequency (RF) energy for treating tissue, such as Monopolar Radiofrequency Energy. The Viveve System also uses a cryogen surface cooling that enables volumetric heating of vaginal tissue. The Viveve System also uses a proprietary, controlled cryogen surface cooling that enables deep volumetric heating of vaginal tissue. The firm's subsidiary includes Viveve, Inc. and Viveve BV.

VIVE Intrinsic Value
Not Available

See Also

What is Viveve Medical Inc's Selling, General & Administrative?
Selling, General & Administrative
-13.5m USD

Based on the financial report for Sep 30, 2022, Viveve Medical Inc's Selling, General & Administrative amounts to -13.5m USD.

What is Viveve Medical Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-18%

Over the last year, the Selling, General & Administrative growth was -7%. The average annual Selling, General & Administrative growth rates for Viveve Medical Inc have been 22% over the past three years , 11% over the past five years , and -18% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett